RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Angel Lopez-Candales to Anticholesteremic Agents

Back to Details
This is a "connection" page, showing publications Angel Lopez-Candales has written about Anticholesteremic Agents.
Angel Lopez-Candales
Connection Strength
0.769
Anticholesteremic Agents
  1. Lopez-Candales A, Vallurupalli S. PCSK9 Inhibition-A Tale of 2 Potential Treatment Opportunities. JAMA Cardiol. 2021 04 01; 6(4):480-481.
    View in: PubMed
    Score: 0.769
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support